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Abstract
The aim was to develop a hybrid three-dimensional-tissue engineering construct for chondrogenesis. The hypothesis was
that they support chondrogenesis. A biodegradable, highly porous polycaprolactone-grate was produced by solid free-
form fabrication. The polycaprolactone support was coated with a chitosan/polyethylene oxide nanofibre sheet produced
by electrospinning. Transforming growth factor-b3-induced chondrogenesis was followed using the following markers:
sex determining region Y/-box 9, runt-related transcription factor 2 and collagen II and X in quantitative real-time
polymerase chain reaction, histology and immunostaining. A polycaprolactone-grate and an optimized chitosan/poly-
ethylene oxide nanofibre sheet supported cellular aggregation, chondrogenesis and matrix formation. In tissue engin-
eering constructs, the sheets were seeded first with mesenchymal stem cells and then piled up according to the lasagne
principle. The advantages of such a construct are (1) the cells do not need to migrate to the tissue engineering construct
and therefore pore size and interconnectivity problems are omitted and (2) the cell-tight nanofibre sheet and collagen-
fibre network mimic a cell culture platform for mesenchymal stem cells/chondrocytes (preventing escape) and hinders in-
growth of fibroblasts and fibrous scarring (preventing capture). This allows time for the slowly progressing, multiphase
true cartilage regeneration.
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Introduction
Osteoarthritis is the most common condition with
adverse effects on the articular cartilage of the human
joints. Due to the limited potential of the adult articular
cartilage to regenerate and repair, treatment of cartil-
age defects is one of the most important problems in
orthopaedic surgery.1 A technology able to achieve
hyaline cartilage repair has been estimated to have a
potential market worth of $300 million to $1 billion
in the United State alone.2
Articular cartilage has poor repair properties
because it consists largely of avascular and aneural
extracellular cartilage matrix, whereas cells occupy
only 1–2% of the total cartilage volume. The metabolic
and mitotic rates of the cartilage cells are low.
Spontaneous cartilage regeneration is not possible
after a significant cartilage injury. Attempts to repair
cartilage defects have been made by drilling holes
(‘microfractures’) into subchondral bone to stimulate
healing by recruitment of bone marrow-derived
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mesenchymal stem cells (MSCs).3 The first cell
therapeutic approach for cartilage regeneration was
autologous chondrocyte implantation (ACI),4 in
which autologous chondrocytes are harvested,
expanded in vitro, injected into the cartilage defect
and covered with a periosteal membrane or a collagen
flap. Later on so-called combination products were
developed, in which chondrocytes are grown on a car-
rier membrane (matrix-induced autologous chondro-
cyte implantation, MACI)5 or in a scaffold.6,7
The materials most commonly used for scaffolds are
the Food andDrug Administration-approved biodegrad-
able polyglycolic acid, poly(L)lactic acid (PLLA), polyca-
prolactone (PCL), poly(ethylene glycol)-terephthalate/
poly(butylenes terephthalate) and collagen.8 Injectable
hydrogels have been tried as scaffolds for cartilage cell
therapy.9 Ideally, an artificial cartilage scaffold should
have (i) optimized three-dimensional (3D) pores and
interconnectivity to allow cellular in-growth, flow trans-
port of nutrients and metabolic waste; (ii) biocompatibil-
ity and preferably bioresorbability with a resorbtion rate
to match cell/tissue growth and to allow true regener-
ation; (iii) suitable surface chemistry and topography
for attachment, proliferation and differentiation of the
seeded cells, (iv) proper mechanical properties to provide
physical support for the cells and to match properties of
the tissue at the site of implantation and (v) fluid state or
small size for mini-invasive application (arthroscopic
implantation) or stiff enough for press-fit fixation
(implantation in an open surgery of a joint).10,11
3D and highly porous scaffolds can be fabricated by
fibre bonding, sintering, solvent casting, particulate
leaching, membrane lamination, melt moulding, tem-
perature-induced phase separation, gas foaming and
rapid prototyping.12,13 The rapid prototyping tech-
niques, such as fused deposition modelling, selective
laser sintering, 3D printing and solid freeform fabrica-
tion (SFF), are particularly promising methods
for production of customer-designed scaffolds with a
patient-specific geometry and controlled internal archi-
tecture, which can be designed with Computer-Aided
Design software. Electrospinning (ESP) allows produc-
tion of biomimetic and bioactive nanofibre scaffolds for
musculoskeletal (including bone, cartilage, ligament
and skeletal muscle), skin, vascular and neural tissue
engineering (TE).14 Combining factors like fibre diam-
eters, morphology, topology, alignment and biochem-
ical properties tissue regeneration can be controlled.
Potential chondrocyte sources include articular
cartilage, ear, nose and ribs. Chondrocytes can also
be produced from embryonic stem cells,15 foetal
cells16 and MSCs harvested from bone marrow, adipose
tissue, synovium, muscle, tendon, periosteum or syn-
ovial fluid.17 MSCs can differentiate to chondrocytes,
resistant to terminal differentiation to bone and to
dedifferentiation to progenitors.18
Taking into account the advantages of SFF and
ESP, we combined them to fabricate different hybrid
micro–nanofibre scaffolds for cartilage regeneration.
The hypothesis was that 3D microfibre/nanofibre
hybrid scaffolds loaded with MSCs layer-by-layer and
induced to chondrogenesis support colonization, viabil-
ity, chondrogenesis and cartilage matrix formation.
Materials and methods
Production of the microfibre/nanofibre
scaffolds in outline
A method called in-line fabrication was used for the
fabrication of the final hybrid scaffolds. It consisted
of the fabrication of microfibre scaffolds using the
SFF method and then ESP a sealing nanofibre sheet
around the supporting microfibre scaffold (Figure 1).
The nanofibrous coating was then partially removed
from the upper side of the scaffold in order to allow
deposition of the cells in its interior. In this way, the
part of the coating remains on the bottom side of the
grate constituting its seal. All steps could be repeated
and modified until the required height, architecture,
biomechanical and biocompatibility properties would
be achieved. For instance, in Figure 1 nanofibres are
directly electrospun on a 3-layer support. Later these
individual but manually manageable and sterilized
small 3D-scaffolds were seeded with cells to a
monolayer TE construct. Monolayer TE constructs
were then, using the lasagne principle, piled up layer-












Figure 1. In-line fabrication method of making microfibre/nanofibre hybrid scaffold.
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Production of supporting microfibre PCL
scaffolds by a SFF
The microfibre scaffolds (Ø 6.4mm 1mm) were made
of PCL (the number average molecular weight Mn
ca. 80,000; Sigma-Aldrich, Poznań, Poland) using
SFF (BioScaffolder System; SysEng, Hünxe,
Germany) according to the method described by
Swieszkowski et al.13 Although the melting point of
PCL is ca. þ60C, the processing temperature was set
to 95 5C to properly extrude polymer melt. The
polymer melt was extruded out through a 25-gauge
needle (Ø¼ 250 mm) by an auger screw rotating with a
speed of 250 rpm and using an air pressure of 8 bars.
The designed strand distance was 600 mm. The lay-
down patterns of 0/60/120 or 0/90 were programmed
to form scaffolds with honeycomb-like patterns con-
taining triangular or square macropores.
Preparation of spinning solutions
Polyethylene oxide (PEO; Sigma-Aldrich, Seelze,
Germany) was used as a carrier polymer. Two water
solutions, 2 % chitosan (type FG-90, medical grade,
Mw¼ 346.0 kD, DD¼ 82.2%, ash content 0.28%
heavy metal content 0.02%; Primex ehf, Siglufjordur,
Iceland), in 1% dilute acetic acid with 1% of nonionic
surfactant Triton X10019 and 2–5% PEO (6 105 to
4 106g/mol) in water were mixed to obtain different
chitosan-to-PEO mass ratios. Spinning solutions were
characterized by the measurement of the dynamic
viscosity (Brookfield Viscometer, Middleboro, MA,
USA) and the surface tension using a stalagmometric
method. Preparation of spinning solutions and assess
their parameters were carried out at a temperature of
20–22C without humidity control. Only chitosan was
weighted after its conditioning at 65% humidity. Due
to the presence of well-conductive dilute acetic acid in
the spinning solutions, their electrical conductivities
were not measured.
ESP technique
All flat nanofibre scaffolds were manufactured based on
two different stations (A and B) for ESP20 (Figure 2).
Station A – allows for quick start-up ESP and easy
sampling. Hence usually was used to determine the rele-
vant process parameters. In particular, after suitable
modification, as described in A hybrid PCL-grate sup-
port covered with a chitosan/PEO composite nanofibre
sheet section, it was used for the direct implementation
of the nanofibrous seal coating on the PCL-grates.
Station B – allows ESP (while maintaining the param-
eters established in advance on the A) nano/microfi-
brous mats uniform thickness and large area. Often,
the manufacturing process takes several hours.
The resultant coating is suitable on investigation
according to the standards for evaluation for the non-
woven textile and other methods. It can serve as a sub-
strate for cell culture, part of the dressing, scaffold,
composite, etc. Most of the ESP experiments were car-
ried out in laboratory conditions with the room and
spinning liquid temperatures being 20–22C and the
relative humidity ca. 65%. In some experiments, the
temperatures of both the room and spinning liquid
were increased to 32–35C. In the room temperature
experiments, 0.3 mm nanofibres and 7 mm microfibres
were produced, whereas at 32–35C homogenous,
0.3 mm nanofibres were produced. The spinning liquid
for ESP performed at 32–35C needs a sufficiently high
viscosity, which was adjusted by the use of PEO with a
high enough molecular weight.
The station A is based on a stand made of
electrically insulating materials, which do not move
during the work phase. The stand is mounted on a
plastic table and has a vertically movable arm for the
adjustment of the height of the ESP head. An electric-
ally grounded sheet of aluminium foil is placed on the
table to fulfil the role of a collecting electrode. The ESP
head is connected to high voltage (ES50P-20W;
Ormond Beach, FL, USA), which was typically
20 kV. In most cases, the distance between the bottom
of the spinning head and the aluminium collecting elec-
trode was 20 cm and the max spinning area was
20 cm 20 cm. The system is equipped with a small
peristaltic pump, which creates air pressure to crowd
the spinning liquid from the spinning head. The pres-
sure was controlled by a U-pipe manometer with water
and was always less than 4 cm H2O.
The station B is based on a grounded rotating tube,
which is covered with a sheet of thin aluminium foil as a
collecting electrode. The ESP head is clamped to a
stand, which moves back and forth along the track
along the rotating tube, on a fixed distance over it.
The rotating velocity was usually 10 rpm and the ESP
head speed was 2 cm/min.
Induction of water resistance of the chitosan/PEO
nanofibres
The fresh electrospun composite nanofibres produced
from a blend of chitosan and PEO are not ready to use
because they are unstable in water. Chitosan/PEO
nanofibres were cross-linked in open jars in hermetic
chambers in 25% water solution of glutaraldehyde for
24 h at 22C to induce water resistance. Shorter time of
cross-linking did not prevent transformation of the
nanofibre sheet to a gel in water. Glutaraldehyde-
mediated cross-linking may leave free and harmful
aldehyde groups inside the nanofibres. Chemical
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neutralization of the free aldehyde groups was carried
out using a water solution of glycine. Based on literature,
0.1N glycine in water is enough for neutralization of the
aldehyde groups,21 but we used 10 times greater 1N
concentrations, usually for 6 h. Drying the chitosan-
containing fibrous materials may lead to problems in
maintaining the flatness and continuity of the sheet,
hence various drying procedures, described in Chitosan/
PEO composite nanofibre sheets section, were tested.
Nanofibre sheets were tested for the fibre size, sheet
thickness, surface mass, apparent density, elongation at
break at maximum tension, tensile strength, bursting
strength (multidirectional strength, ball perforation),
bending rigidity and structural resistance to handling
of the sheets in water and air. Some of them were
estimated according to the following standards:
Tensile strength and elongation at break – BS EN
29073-3:1994, thickness – BS EN ISO 9073-2:2002, sur-
face mass – BS EN 29073-1:1994, apparent density –
calculated by dividing the mass of the sample surface by
the thickness, bending rigidity – PN-73/P-04631 and
bursting strength – PN-79/P-04738. The last more
commonly known as the EN ISO 9073-5:2008
‘Determination of resistance to mechanical penetration
(ball burst procedure)’ determines the resistance to
mechanical penetration of nonwoven fabrics. This stand-
ard specifies a method for determination of multidirec-
tional strength of nonwoven and is carried out based on
measurement force needed to nonwoven perforation by
ball moving with constant velocity. At the first three
Instron 5540 tensile testing machine was used.
Sterilization
All implant scaffolds used in this study were sterilized
with gamma radiation (total dose 27 3 kGy) prior to
cell culture in the Laboratory of Radiochemistry,
Department of Chemistry, University of Helsinki,
Finland.
Cell culture
PoieticsTM Human MSC (Lonza Walkersville Inc.,









Figure 2. A scheme of two different electrospinning stations. Station A is based on an immovable stand and station B on a rotating
tube. 1 – An electrospinning multijet head; 2 – a set-up stand; 3 – a movable stand; 4 – an aluminium foil; 5 – a rotating tube; 6 – a high
voltage power supply; 7 – a peristaltic pump and 8 – an U-pipe water manometer. The arrows indicate ability to adjust (bold) or to
move (thin).
876 Journal of Biomaterials Applications 30(6)
 at University of Helsinki on February 4, 2016jba.sagepub.comDownloaded from 
media (PT-3001, Lonza Walkersville Inc.) to
confluence. Seeding density was 5–6 103/cm2 and
cells were refreshed 2–3 per week. For detachment,
0.25% trypsin in PBS-EDTA was used and after cen-
trifugation 600 g for 5min cells were counted with Z1
Coulter Particle Counter (Beckman Coulter, Fullerton,
CA, USA) with the window set to 6–24mm.
For chondrogenesis, 10 ng/ml recombinant human
transforming growth factor b3 (243-B3; R&D
Systems, Minneapolis, MN, USA or produced in
house) was used as a required stimulant in chondro-
genic differentiation media (PT-3003; Lonza
Walkersville Inc.). The hMSC chondrogenic differenti-
ation medium is offered as a BulletKitTM including
serum containing medium with the necessary supple-
ments and growth factors (dexamethasone, ascorbate,
insulin, sodium pyruvate, proline and L-glutamine) as
also antibiotics (30mg/ml gentamicin and 15 ng/ml
amphotericin). First 2.5 105 cells were seeded separ-
ately on three different cell culture platforms
(composed of the nanofibre sheets) on top of the sup-
porting PCL-grate. These monolayers were cultured for
1 week separately in Chamber Slides (16 wells/slide, á
0.4 cm2; Lab-Tek, Roskilde, Germany). After this pre-
culture, the monolayer TE sheets were according to the
lasagne principle manually assembled to a three-layer
3D-TE construct. The total chondrogenic culture time
was 28 days, after which the 3D-TE constructs were
fixed in 10% formalin over night, dehydrated 3 2min
in a graded ethanol series (70–80–96%) and incubated
for 2 h in infiltration solution before embedding in
Historesin (Historesin Embedding Kit; Leica, Wetzlar,
Germany). 3–6 mm slices were cut with RM 2165
Microtome (Leica) on Ultraþ slides using Tungsten
Carbide knife. Cultures with TE construct were
repeated six times.
For messenger RNA (mRNA) and histochemical
analysis MSCs were also cultured with and without
chitosan/PEO fibre sheet in 16-well Chamber Slides as
above, 2.5 105 cells/well. Cells were seeded at day 0,
allowed to attach and time points 1, 7, 14, 21 and
28 days were collected for RNA extraction and day
28 fixed for histochemistry. Each culture was done at
least three times.
Histochemistry
Cells on TE construct were stained with 1% toluidine
blue in acetate-HCl buffer (pH 2). Cells on chitosan/
PEO fibre sheet were stained with nuclear 40,6-diami-
dino-2-phenylindole (DAPI) stain and were inspected
under ultraviolet or bright field using Olympus AX70
microscope (Olympus Corp., Tokyo, Japan). Images
were acquired with a 12-bit CD camera (PCO CCD;
SensiCam, Kelheim, Germany) and analysed using a
semiautomatic AnalySis Pro 3.0 image analysis and
processing software (Soft Analysis System GmbH,
Münster, Germany).
Thin 3–6 mm historesin slices of TE constructs were
deparaffinized and rehydrated. Antigen retrieval was
performed at 37C in 4mg/ml pepsin in 0.1M HCl
for 45min or at 98C in 0.01M sodium citrate pH 6.0
in Micromed T/T Mega Laboratory Microwave System
(Milestone, Sorisole, Italy) using a specific retrieval
program, followed by cooling down at 22C for
20min. Slides were rinsed in dH2O, washed in PBS
and incubated in (1) 1% H2O2 in PBS for 15min to
block the endogenous peroxidase; (2) 10% normal
goat serum (Vector Laboratories, Burlingame, CA)
for 1 h; (3) rabbit anticollagen type II (Cedarlane,
Ontario, Canada) or nonimmune rabbit IgG (R&D
Systems) 1:50 in 0.1% BSA-PBS overnight at 4C; (4)
biotin-conjugated goat anti-rabbit IgG antibodies
(Vector Laboratories; 1:200 in 0.1% BSA-PBS for 1 h
and (5) avidin–biotin–peroxidase complex (ABC com-
plex, 1:200 in dH2O, Vector Laboratories) for 1 and 6 h
in 0.006% H2O2 substrate and 3,3-diaminobenzidine
chromogen solution (SigmafastTM tablets; Sigma-
Aldrich, Seelze, Germany) for 10min. Slides were coun-
terstained in hematoxyline, air dried and mounted in
Mountex (HistoLab, Gothenburg, Sweden). Slides were
analysed and photographed using Leica DM6000
microscope and 5 megapixel Leica DFC420 digital
camera (Leica Microsystems) and images were analysed
using a Leica Microsystems LAS AF application
(Leica).
Quantitative real-time polymerase chain reaction
Total RNA was isolated by RNeasy Mini Kit (Qiagen,
Valencia, CA, USA). Complementary DNA (cDNA)
was prepared from 100 ng total RNA using iScript
cDNA synthesis kit (Bio-Rad Lab, Hercules, CA,
USA) with a blend of oligo (dT) and random hexamers
to prime first-strand and RNase Hþ iScript reverse
transcriptase for cDNA synthesis. Sense and antisense
primers were designed using primer design software
Primer3 (Table 1). For primers corresponding
sequences were searched from NCBI Entrez search
system, sequence similarity searches were done using
NCBI blastn program and primers produced by
Oligomer (Helsinki, Finland). Quantitative polymerase
chain reaction (PCR) was run using 2 ml cDNA
and 250 nM primers in iQ SYBR Green supermix by
iQ5 PCR machine (Bio-Rad Lab). Relative mRNA
expression was normalized per four most suitable and
unregulated housekeeping genes tested, b-actin,
porphobilinogen deaminase (PBGD), hypoxanthine
guanine phosphoribosyltransferase and glyceraldehyde
3-phosphate dehydrogenase. Markers used were sex
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determining region Y/-box 9 (SOX9), runt-related tran-
scription factor 2 (RUNX2) and collagen type II
(COL2A1) and collagen type X (COL10A1). Each indi-
vidual sample was amplified at least three times for all
genes of interest. The differences between groups were
investigated with Mann Whitney U test in OriginPro
8.6 statistics. p< 0.05 was considered as a statistically
significant.
Results and discussion
Chitosan/PEO composite nanofibre sheets
Fragile and flat nanofibre sheets were electrospun on
collectors or directly on thicker and mechanically more
durable supporting PCL-grate supports. Nanofibre
sheets were used to seal the large pores (cellular sinks)
and to provide a collagen nanofibre mimic growth plat-
form composed of chitosan/PEO nanofibres. This
arrangement enabled convenient manipulation and
handling both of the single nanofibre sheets and of
the nanofibre sheets at the top of the monolayer
hybrid scaffolds during various physical, chemical and
cellular treatments. The thin chitosan/PEO nanofibre
sheets were produced in a multistep process consisting
of preparation of the spinning solution, ESP, prepar-
ation of sheets of appropriate size, thickness and mesh
size, cross-linking of the nanofibres with glutaralde-
hyde, soaking in an aqueous solution of glycine,
plasticizing with glycerine, drying and trimming. The
chitosan/PEO nanofibre sheets produced were water
resistant, nontoxic, plastic and cell friendly. For achiev-
ing all these features for chitosan nanofibrous mater-
ials, it is not yet possible to obtain in a simple one-step
process, for example by ESP alone. ESP from solutions
of chitosan could be done with use of concentrated
trifluoroacetic acid, TFA22 or mixture TFA/dichloro-
methane,23 which are spinnable and in these cases the
help of PEO as a carrier polymer would not be neces-
sary. However, chitosan fibres obtained in this way are
unstable in water and require further treatment as the
fibres of chitosan/PEO, or similar. For example we have
used those efficiently in our practice treating them in a
properly prepared alkaline environment. Moreover, the
solvents are chemically aggressive and quickly cause
major molecular degradation of chitosan, which leads
to instability of spinning solutions over time and
decreases the quality of polymeric material in fibres.
It should be emphasized that all the steps up to
drying were optimized. Water-acid chitosan solution
has no spinning ability in the ESP sense. PEO was
very suitable as a carrier polymer because it is a
water-soluble polymer available in a very wide molecu-
lar mass range and because it can be used in medical
applications to adjust the viscosity of the spinning solu-
tion. Final chitosan-to-PEO mass ratios 80:20 and
60:40 worked best in our experiments. The dynamic
viscosity of these spinning solutions was 376–486 cP.
Use of the nonionic Triton X100 surfactant19,24 (applic-
able for medical purposes) additive in the spinning
solution decreased the surface tension almost to half
(from 85 to 41–46 dyne/cm), which greatly improved
spinnability. This latter modification practically omits
the formation of beads in spun fibrous material, which
are usually caused by too high surface tension of the
spinning solution. The use of the surfactant in an
amount of 1% by weight on the solution is sufficient
and by increasing its share to the level of 2–3% by
weight does not lead to a visible change (scanning elec-
tron microscopy [SEM] studies) in quality of spun
material. This ingredient is probably almost entirely
removed from the material of the fibres during further
water processing as a low molecular weight substance
with excellent solubility in water. At 20–22C two
modal fibres structures, nanofibres with diameter
about 0.3 mm and microfibres with diameter about
Table 1. Primers used in quantitative real-time polymerase chain reaction (qRT-PCR).
Name Sense Antisense bp
-Actin TCACCCACACTGTGCCCATCTACGA CAGCGGAACCGCTCATTGCCAATGG 295
PBGD ACATGCCCTGGAGAAGAATG AGATGCGGGAACTTTCTCTG 237
HPRT GCAGACTTTGCTTTCCTTGG AAGCAGATGGCCACAGAACT 321
GAPDH AAGGTCATCCCTGAGCTGAA TGCTGTAGCCAAATTCGTTG 310
SOX9 AGCCAGGTGCTCAAAGGCTAC GCCGCGGCTGGTACTTGTAAT 301
RUNX2 TAGATGGACCTCGGGAACCCAGA TGGAAGACAGCGGGGTGGTAGA 309
COL2A1 GAGTCAAGGGTGATCGTGGT AAGCACCTTGGTCTCCAGAA 303
COL10A1 ACGATACCAAATGCCCACAG CAGCTGGTCCAACATCTCCT 329
The genes of interest, their sequence and the lengths (bp) of RT-PCR products are shown.
COL2A1: collagen type II; COL10A1: collagen type X; HPRT: hypoxanthine guanine phosphoribosyltransferase; GAPDH: glyceraldehyde 3-phosphate
dehydrogenase; PBGD: porphobilinogen deaminase; RUNX2: runt-related transcription factor 2; SOX9: sex determining region Y/-box 9.
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7 mm (and single larger objects) were produced
(Figure 3(a) and (a1)). Use of a slightly raised tempera-
ture up to 32–35C allowed preparing of uniform nano-
fibres with an average diameter of 0.33 mm (Figure 3(b)
and (b1)). It seems that producing non defective nano-
fibrous mats from the ESP process is favourable as a
substrate for living cells. A significant improvement in
fibre quality using ESP chitosan nanofibres from solu-
tions of chitosan/PEO is obtained also in other stu-
dies,25 using even higher temperatures up to 80C.
Crosslinking of chitosan/PEO fibres in glutaraldehyde
pairs for 24 h, as described in Cell culture on TE con-
struct section, gave them stability in water. It can be
expected that crosslinking increases the mechanical
strength of chitosan fibres, but also lose a bit of its
flexibility (their elongation during stretching should
be lower). Therefore, the crosslinking process should
be carried out to obtain sufficient resistance of a fibre
to water, but not long, because the fibres become brit-
tle. Due to the fact that the obtained fibrous material
before the crosslinking in the present study is only a
transitional form and might even damage when in con-
tact with human skin, their mechanical tests were not
performed. Therefore, a comparison of the mechanical
properties of cross-linking chitosan fibres before and
after cross-linking is not currently possible. Cross-
linked fibres do not dissolve in water and they are not
transformed into a gel in noticeably way. This means
that the fibres after treatment with water and drying
retain its shape during the microscopic observation of
SEM. This resistance was checked for fibrous materials
treated in aqueous medium for 5 days. At this time,
samples were taken, dried and observed in the scanning
electron microscope. In case of too weak cross-linking,
the fibres were blurry shapes or even they cannot be
distinguished from the background of the polymer.
Chitosan/PEO 60/40
e-spinning at 20 °C
Chitosan/PEO 60/40
e-spinning at 32 °C
Thin fibres d = 0.37 µm
d = 0.33 µm

























Figure 3. Scanning electron microscopy (SEM) images of fibrous sheets produced from chitosan/PEO blend with a weight ratio of
60:40 by electrospinning at different temperatures: (a) electrospinning at þ20C produced a bimodal distribution of the fibre diam-
eters (a1), corresponding to the both kinds of fibres, nanofibres and microfibres as indicated by the arrows, and (b) Electrospinning at
þ32C produced only nanofibres (b1).
PEO: polyethylene oxide.
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Detoxification of the aldehyde residues were done in an
aqueous solution using glycine. During the glycine
bath, up to half of noncrosslinked PEO, only used as
an additive to facilitate ESP, leached out making the
final chitosan/PEO nanofibres richer in chitosan. PEO
leaching process was monitored qualitatively by analys-
ing the thermal decomposition of chitosan/PEO sam-
ples by thermogravimetric analysis and quantified by
Kjeldahl nitrogen content method. It has been found
that the process is effective only for the first two hours
and then (several days) run very slowly. Thus, it was
assumed that an attempt to completely remove the PEO
to see only chitosan fibres under these conditions is not
possible.
Physicomechanical properties of a nanofibre sheets,
measured at a relative humidity of 65% in accordance
with relevant industrial standards, electrospun at 35C
and composed of nanofibres with an average diameter
of 0.23 mm, are shown in Table 2. The first four features
of the fibrous sheets listed in Table 2 can be modified by
proper selection of the conditions used for manufactur-
ing or by changing other processing parameters.19
With respect to the strength of the current nanofi-
brous sheets, it can be noted, that the filamentous nano-
fibre components are much thinner that those required
for conventional textiles, used, for example to implan-
table vascular grafts. However, currently manufactured
nanofibrous materials form the substrate for cell
growth and act as two-way, cell-tight sealing element,
and will therefore not be exposed to high and pulsating
hydrostatic pressure and shear stress that affect the vas-
cular prostheses. These properties, together with the
supporting PCL-grate support, protect the nanofibrous
sheets from breakdown and disintegration during vari-
ous manual operations.
Currently produced nanofibre chitosan/PEO
composites sheets are very flexible in a high humidity.
A sample sheet can be submerged in water in a Petri
dish (Figure 4(a)). Multiple transfer of the samples, by
picking them up to air and submerging them back in
water do not cause any visible damage (Figure 4(b)).
However, drying of the material sheet to an air-dry
state leads to varying surface deformations and often
to an irreversible damage in the form of cracks
(Figure 4(c)).
Tests were carried out to modify the drying process
of nanofibrous scaffolds to reduce their accidental
deformation and disintegration upon handling. These
modifications consisted of reduction of the rate of
drying, gradual replacement of water by ethyl alcohol
and then drying of the ethanol and freeze-drying. Such
methods of drying noticeably improved the resistance
of the samples against mechanical damage, which still
was not fully satisfactory. It should be noted that
deformations resulting from a considerable shrinkage
of the fibre sheets during the drying process are char-
acteristic for many materials made from polymers of
natural origin and characterized by a high absorption
of moisture. Hence, their use often requires the devel-
opment of an appropriate finishing process. Regarding
the plasticizer, it was found that the best results were
obtained using 40wt% glycerine. In addition, glycerine
retains water. Thus, glycerine-treated nanofibrous
sheets retained the same flexibility state as they had in
high humidity and were resistant to handling stress and
deformations (Figure 4(d)). However, use of this brand
of chitosan/PEO nanofibrous sheet was still somewhat
problematic because glycerine impaired the initial stick-
ing to and facilitated the subsequent detachment of the
nanofibrous chitosan/PEO sheets from the surface of
the supporting macrofibre PCL-grate support. Hence,
in addition to production of single, flat nanofibrous
sheets, an attempt was made to use the ability of ESP
technique to directly cover the carrier element, the
PCL-grate support, with chitosan/PEO nanofibres as
a sealant coating. This procedure is shortly described
below.
A hybrid PCL-grate support covered with a chitosan/
PEO composite nanofibre sheet
To produce a sealing chitosan/PEO composite nanofi-
bre sheet directly on PCL-grates (pretreated with and
without electro conducting surfactant) by ESP required
attachment of the PCL-grate to a copper wire using hot
gluing with a molten PCL granule (Figure 5(a)). The
lay-down patterns of 0/60/120 and 0/90 PCL-grates
were made of microfibres with a diameter of about
300 35 mm. The maximum size of the pores of the
PCL-grates was about 350 50 mm. Copper wire-PCL
























0.23 0.070 9.81 0.140 10.8 1.84 5.78 0.002
aMultidirectional strength (ball perforation).
PEO: polyethylene oxide.
880 Journal of Biomaterials Applications 30(6)




Figure 4. Photographs of fibrous sheets produced of chitosan/PEO nanofibres using a 60:40 starting weight ratio and subjected to
the following treatments: (a) submersed in water in a Petri dish; (b) lifted from the water (and lowered back several times); (c) dried to
an air-dry state; and (d) saturated with glycerine and packaged between polyester meshes for handling. All samples have similar sizes.





Figure 5. Photographs of the manufacture of scaffolds based on thick supporting PCL-grates, coated with a sealing nanofibrous sheet
composed of chitosan/PEO, produced directly on the PCL targets by electrospinning. (a) a PCL-grate is hot-glued with a drop of molten
PCL to a copper wire; (b) scaffolds have been mounted in a conductive cantilever and then located in the zone of electrospinning for
direct coating with nanofibres; (c and d), respectively, show the uncovered bottom and the sealed cell seeding top of the scaffold.
PCL, polycaprolactone.
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constructs were mounted on electro conducting canti-
levers (Figure 5(b)), which could be rotated in the ESP
space during nanofibre coating. After unmounting
from the ESP apparatus and removal of the copper
wire, the central part of the nanofibre sheet was cut
off from the bottom of the PCL-grate (Figure 5(c)),
while the nanofibre sheet (coating) on the cell seeding
face of the implant was retained on the top of it (Figure
5(d)). Cells were seeded from this side of the scaffolds
into the triangular or square macro pores formed
between the PCL-microfibres arranged in a honey-
comb-like patterns. Cells were at the bottom of the
macro pores retained by the sealing chitosan/PEO
nanofibre sheet. These scaffolds were then used in the
actual and final chondrogenic experiments (after
numerous pilots done).
MSC cultures on chitosan/PEO nanofibre sheet
MSCs cultured on chitosan/PEO fibre sheet in a chon-
drogenic induction medium formed spontaneously
aggregates within 24 h (Figure 6). These aggregates
remind the chondrogenic pellets, which are normally
formed when pelleting is used to establish cell-to-cell
contacts to promote chondrogenesis.26
Analysis of chondrocyte markers
during chondrogenesis
Quantitative real-time PCR analysis confirmed a suc-
cessful induction and progression of chondrogenesis of
human bone marrow-derived MSCs cultured in the
chondrogenic induction medium on chitosan/PEO
fibre sheets, but lack of such differentiation upon cul-
ture on regular cell culture plastics. On chitosan/PEO
sheet early chondrocyte markers SOX9 (day 21,
p¼ 0.037 to day 0) and RUNX2 (day 7, p¼ 0.008 to
day 0) are first induced in succession, followed by a
continuously increasing cartilage-specific matrix
protein collagen type II expression, which is higher
than without chitosan/PEO sheets (day 21 and 28,
p¼ 0.032).18 Supporting chondrogenesis, the expression
of collagen type X is diminished and maintained low,
suggesting prevention of chondrocyte hyperthrophy
and osteogenesis (Figure 7(a)).27 In contrast, the regu-
lated flow of events is lost in MSC cultured on regular
cell culture plastics, with only a transient and
short peak of collagen type II expression, but without
subsequent progression, highly increased collagen type
X expression (day 7, p¼ 0.029 and day 29, p¼ 0.043 to
chitosan/PEO), suggesting transition of the chondro-
genesis to osteogenesis (Figure 7(b)).
Cell culture on TE construct
Final 3D-TE constructs were formed by piling up three
MSC seeded and precultured 2D-monolayers, com-
posed of the PCL-grate support and an overlying (dir-
ectly electrospun) chitosan/PEO nanofibre sheet
scaffolds.
Such 3D-TE constructs were cut to 4–20-mm thick
sections with a regular histological microtome and
stained with toluidine blue, which allows examination
of the TE construct structure, but also of the TE
morphology inside the lasagne scaffolds, e.g. cartilage
proteins proteoglycan and collagen (Figure 8(a)).28
At culture day 28 such 3D-TE constructs contained
chondrocytes in cartilage matrix, located already iso-
lated in their lacunae (Figure 8(b) and (c)).29
Although the cartilage was still relatively hypercellular,
these MSC-produced chondrocytes produce type II col-
lagen-rich matrix as was shown in immunostaining
(Figure 9(a)), with a negative control staining using
normal rabbit IgG at the same concentration as and
instead of the specific primary antibodies confirming
the specificity of the staining (Figure 9(b)).
(a) (b)
Figure 6. Initial differentiation of mesenchymal stem cells cultured in a chondrogenic induction medium on chitosan/PEO fibre sheet.
(a) Fluorescence of nuclei in a 40,6-diamidino-2-phenylindole (DAPI) staining and (b) morphology of a cell pellet in a bright field
microscopy. Scale bar 100 mm.
PEO: polyethylene oxide.
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The principles of regenerative medicine,30 use of
MSC in regenerative medicine and TE applications31
and this particular approach in chondrogenesis6 have
been reviewed in some detail in a series of articles. The
current chondrogenic approach has considerable com-
mercial potential, as is suggested by the success of ACI
with a periosteal or collagen membrane, the second-
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Figure 7. Messenger RNA expression of chondrogenic differentiation markers in (a) differentiating stem cells growing on chitosan/
PEO fibre sheet or (b) without fibre sheet. Relative expression to day zero.
PEO: polyethylene oxide.
(a) (b) (c)
Figure 8. (a) A vertical section of a 3D-tissue engineering (TE) construct showing here three PCL layers of the support grate. (b)
Stem cells undergo chondrogenic differentiation inside the TE construct and (c) a higher magnification shows already a typical lacuna-
like structure with a chondrocyte, surrounded by cartilaginous matrix. Scale bar in panel a 500 mm and in panel b 20mm.
PCL, polycaprolactone.
(a) (b)
Figure 9. Immunohistochemical staining of (a) extracellular matrix collagen type II and (b) control nonimmune IgG of differentiated
cells inside the tissue engineering construct. Scale bar 50mm.
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assisted TE approaches.32 To approach and reach this
goal, intimate co-operation between material, physical
and medical scientists is necessary.
Our intention was to study the biocompatibility of
3D composite scaffolds made of structurally supporting
micron-size fibres to attain mechanical strength and
good handling properties and of collagen fibre mimick-
ing nanofibre sheets to attain a good growth and dif-
ferentiation potential. The function of the last
mentioned nanofibrous sheet is twofold. First, it pro-
vides a culture substrate platform for the seeded cells
for differentiation and matrix synthesis. Second, the
sealing 2D nanofibre sheets in the 3D-TE constructs
prevent detachment and escape of the MSCs, cellular
aggregates, chondrogenic cells and of the forming car-
tilage. In particular, sealing nanofibrous sheets prevent
capture of the scaffold by the in-growth of the rapidly
migrating, proliferating and scar tissue forming fibro-
blasts. This is necessary because chondrogenesis from
MSCs and synthesis of the cartilage matrix by already
differentiated cells are slow processes. Full cartilage
regeneration requires therefore time. In deep and super-
ficial cartilage lesions there is a tendency that fibrocar-
tilaginous tissue at a rapid pace fills the cartilage tissue
defects produced by traumatic or arthritic cartilage
lesions, thus preventing any subsequent attempts to
replace the defect area with the original tissue, with
the truly hyaline articular cartilage.
One of the challenges was to transfer the MSC-to-
chondrocyte differentiation from the cellular pellets to
TE scaffolds, but this was possible with the use of 3D
PCL-chitosan/PEO hybrid scaffolds and human bone
marrow-derived MSCs. It was particularly important
to demonstrate that chondrogenesis, from the early cel-
lular pelleting and initial cell–cell contact phase could
progress to chondrocytic differentiation and subsequent
synthesis of the cartilage matrix in lasagne-type, multi-
layer implants. One of the advantages of this lasagne-
type assembly of tissue engineered monolayers is that
the slowly migrating cells do not need to intrude to the
superficial pores and then further through the intercon-
nected pores deeper into the centre of the bulky
implant. Cells are seeded separately on the monolayer
constructs, which are tough and easy to pile up, one
upon the other, into a multilayer. The energy required
for the synthetic and migratory, haptotactic activities is
saved and all the matrix of the TE construct is from the
very beginning occupied by stem cells.
We launched the lasagne principle. As mentioned
above, nanosize fibres support the chondro-inductive
differentiation and protect against chondroptosis and
matrix degradation, but also confine the cells to their
own territorial domains, with ‘no way out’ (escape) for
the repair cells but ‘no way in’ either for the scar form-
ing fibroblasts (capture). Indeed, fibrocartilage is
produced when the widely used mosaicplasty is used
to ‘heal’ cartilage defects with a method, which leads
to bleeding from the bone marrow and recruitment of
endogenous bone marrow-derived MSCs but also of
marrow fibroblasts, which then fill the defect with
mechanically inferior (nonelastic) fibrocartilage.
No bioreactor was necessary because the cells, in
spite of quite large TE construct volume in a membran-
ous structure are never very far from oxygen and nutri-
ents, which even the chondrocytes need for matrix
synthesis and maintenance. Cells seeded in the 3D
biomatrix were shown to remain alive and to develop
a chondrocytic phenotype as a result of which they
produce cartilage extracellular matrix.
In conclusion, a new 3D, multilayer PCL-chitosan/
PEO prototype scaffold was produced, suitable for
handling during preparation and processing, enabling
seeding of 2D-scaffolds with cells and then an assembly
of multilayer 3D-TE constructs for different size lesions
but always with even distribution of the cells inside the
TE-implant. Such biomaterial matrix supported both
the initial and late phase of chondrogenesis.
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